共 50 条
- [41] The Problems that Occurred after Discontinuation of Efalizumab Therapy in Psoriasis PatientsTURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2010, 44 (01): : 19 - 24Adisen, EsraTezel, FulyaGurer, Mehmet Ali
- [42] Biological therapy for psoriasis: An overview of infliximab, etanercept, efalizumab and alefaceptIDRUGS, 2004, 7 (01) : 45 - 49Tutrone, WDSaini, RWeinberg, JM
- [43] An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasisCLINICAL THERAPEUTICS, 2003, 25 (10) : 2487 - 2505Weinberg, JM
- [44] Efalizumab A Review of its Use in the Management of Chronic Moderate-to-Severe Plaque PsoriasisAMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2009, 10 (01) : 51 - 72Frampton, James E.Plosker, Greg L.
- [45] Severe Plaque Psoriasis cum pustulatione - Significant Improvement by Treatment with Efalizumab (Raptiva((R)))AKTUELLE DERMATOLOGIE, 2006, 32 (8-9) : 379 - 381Thiel, W.Kowalzick, L.
- [46] Long-term efficacy of up to 15 months' efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasisDERMATOLOGIC THERAPY, 2008, 21 : S6 - S14Toth, Darryl P.Papp, KimGratton, David
- [47] Efficacy and safety of adalimumab, efalizumab and etanercept in the treatment of plaque-psoriasis 'in daily practice'JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 25 - 25Richter, L.Marker, M.Monshi, B.Mueksch, S. RichterRappersberger, K.
- [48] The safety of efalizumab in patients with moderate to severe plaque psoriasis: Summary of clinical trial experienceJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P157 - P157Leonardi, CGoffe, BSobell, JCaro, I
- [49] Efalizumab (Raptiva) for treatment of psoriasisMEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1171): : 97 - 98不详